US 9457070
Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
granted A61KA61K2035/124A61K31/60
Quick answer
US patent 9457070 (Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2035/124, A61K31/60, A61K35/28, A61K38/12